Bayer Proposes $7.25B Roundup Weed Killer Settlement

Bayer Proposes $7.25B Roundup Weed Killer Settlement

Editor & Community Manager

February 19, 2026 11:37 AM

Update: The court granted preliminary approval of the Roundup exposure settlement on March 4, 2026.

Individuals exposed to Roundup or other glyphosate-based weed killers before Feb. 17, 2026, may be eligible to submit a claim to receive a cash payment from a proposed class action settlement . Class counsel filed a motion for preliminary approval of the settlement on Feb. 17, 2026.

Bayer, which acquired Monsanto in 2018, agreed to pay up to $7.25 billion to settle a class action lawsuit alleging exposure to Roundup and other glyphosate-containing weed killers can cause non-Hodgkin lymphoma. Individuals have made an estimated 200,000 claims against Bayer, alleging the dangers of the weed killer that first became available for agricultural and consumer use in 1974.

The settlement includes all 50 United States, the District of Columbia, Puerto Rico, Guam, American Samoa, the U.S. Virgin Islands, the Northern Mariana Islands and any other United States territory and military or diplomatic establishment throughout the world.

Who will qualify to file a claim for a Roundup payout?

Class members must meet the following proposed criteria:

• They are a U.S. citizen or non-U.S. citizen living in the United States on Feb. 17, 2026.
• They were exposed to Roundup or other glyphosate-based weed killers in the United States before the date of preliminary approval.
• They had contact with, inhaled, ingested or absorbed Roundup products in the United States before Feb. 17, 2026.
• The exposure occurred because the class member:
• Applied the products themselves
• Purchased or paid for the products or their application
• Participated in, directed or saw the application of the products
• Otherwise had reason to know they were exposed

Subclasses and claimant types

The settlement divides class members into two main groups:

• Subclass 1: Individuals diagnosed with non-Hodgkin lymphoma as of Feb. 17, 2026, and who meet the exposure requirements
• Subclass 2: Individuals who meet the exposure requirements but have not been diagnosed with NHL as of Feb. 17, 2026. These individuals can only submit a claim if they are diagnosed in the future.

The settlement categorizes claimants as:

• Occupational claimants: Class members who were exposed to Roundup products for more than 80 hours in an agricultural, industrial, turf or ornamental job and earned more than 50% of their income or more than $15,000 from this job in at least one year
• Residential claimants: Class members who were exposed to Roundup products in a residential capacity or who do not meet the occupational thresholds

The settlement also includes:

• Derivative claimants: Spouses, parents or dependent children of a class member or those with a legal relationship that allows them to sue based on a loved one’s exposure
• Representative claimants: Legal representatives, executors or administrators acting on behalf of deceased or incapacitated exposed persons

Who is excluded from the class?

Certain individuals cannot file a claim:

• Individuals who watched someone else apply Roundup products without knowing they were herbicides
• Individuals who already settled their claim with Monsanto and signed a release
• Individuals whose Roundup injury claims a court previously dismissed
• Individuals with a claim pending in the federal multidistrict litigation in California, known as In re Roundup Products Liability Litigation, MDL No. 2741, as of Feb. 17, 2026, unless they dismiss their MDL claim and request to join this settlement

Program awards

Most class members with an NHL diagnosis can submit a claim to receive a cash payment based on the type of exposure, age at diagnosis and NHL subtype:

• Occupational, under 60, aggressive NHL: $165,000
• Occupational, 60–77, aggressive NHL: $105,000
• Occupational, under 60, indolent NHL: $85,000